Reversible myopathy after statin therapy in patients with normal creatine kinase levels.
Bennett
William E
WE
Drake
Almond J
AJ
Shakir
K M Mohamed
KM
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D009135:Muscular Diseases / Q000139:chemically induced* / Q000201:enzymology
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D003402:Creatine Kinase